De-escalating chemotherapy for stage II colon cancer?

BACKGROUND: Although adjuvant chemotherapy is recommended for patients with stage II colon cancer characterized by poor prognostic features, its pros and cons remain a controversial issue. We aim to evaluate the real effectiveness of chemotherapy on stage II colon cancer as well as select suitable p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jianfei, Wu, Lunpo, Ge, Chenyang, Xu, Tiantian, Li, Dan, Fu, Wei, Wang, Liangjing, Du, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710694/
https://www.ncbi.nlm.nih.gov/pubmed/31489031
http://dx.doi.org/10.1177/1756284819867553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710694/
https://www.ncbi.nlm.nih.gov/pubmed/31489031
http://dx.doi.org/10.1177/1756284819867553

Ejemplares similares